In fact, glycogenolysis and subsequent hyperglycemia could be almost completely prevented when Fabp4 was either genetically deleted or pharmacologically neutralized, despite an intact increase in glucagon level (24). This evidence concerns the gene FABP4 and Hyperglycemia.